Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial

2010275 citationsJournal Articlehybrid Open Access

Authors

Takaya Maruyama

Osamu Taguchi · Mie University

Michael S. Niederman · Winthrop-University Hospital

John Morser · Stanford Medicine

Hirofumi Kobayashi · Mie University

Tetsu Kobayashi · Mie University

Corina N. D’Alessandro‐Gabazza · Mie University

Abstract

The 23-valent pneumococcal polysaccharide vaccine prevented pneumococcal pneumonia and reduced mortality from pneumococcal pneumonia in nursing home residents. Trial registration Japan Medical Association Center for Clinical Trials JMA-IIA00024.

Topics & Keywords

Pneumonia and Respiratory Infections Bacterial Infections and Vaccines Respiratory viral infections research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMJ

Volume 340, Issue mar08 1, pp. c1004-c1004

DOI: 10.1136/bmj.c1004

Field-Weighted Citation Impact: 15.94